Catalyst Pharm Inc
(CPRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 161,628 | 108,845 | 56,737 | 163,889 | 107,953 |
| Depreciation Amortization | 28,336 | 18,920 | 9,460 | 37,774 | 28,316 |
| Income taxes - deferred | -2,338 | -4,755 | -2,321 | -9,388 | -11,943 |
| Accounts receivable | -40,933 | -387 | -5,789 | -11,962 | -4,752 |
| Accounts payable and accrued liabilities | -7,497 | -11,065 | -5,396 | 1,798 | -3,232 |
| Other Working Capital | -45,728 | -6,105 | -7,051 | 30,914 | 26,467 |
| Other Operating Activity | 70,311 | 25,888 | 14,403 | 26,783 | 26,122 |
| Operating Cash Flow | $163,779 | $131,341 | $60,043 | $239,808 | $168,931 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -26 | -26 | N/A | -556 | -468 |
| Investing Cash Flow | $-26 | $-26 | $0 | $-556 | $-468 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12,793 | 6,997 | 4,787 | 154,515 | 148,531 |
| Other Financing Activity | -4,207 | -3,065 | -1,727 | -13,850 | -12,299 |
| Financing Cash Flow | $8,586 | $3,932 | $3,060 | $140,665 | $136,232 |
| Beginning Cash Position | 517,553 | 517,553 | 517,553 | 137,636 | 137,636 |
| End Cash Position | 689,892 | 652,800 | 580,656 | 517,553 | 442,331 |
| Net Cash Flow | $172,339 | $135,247 | $63,103 | $379,917 | $304,695 |
| Free Cash Flow | |||||
| Operating Cash Flow | 163,779 | 131,341 | 60,043 | 239,808 | 168,931 |
| Capital Expenditure | -26 | -26 | 0 | -556 | -468 |
| Free Cash Flow | 163,753 | 131,315 | 60,043 | 239,252 | 168,463 |